Skip to main content
CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.400
+0.130 (3.98%)
At close: Jun 26, 2026, 4:00 PM EDT
3.390
-0.010 (-0.29%)
After-hours: Jun 26, 2026, 6:36 PM EDT

CytomX Therapeutics Employees

CytomX Therapeutics had 69 employees as of December 31, 2025. The number of employees decreased by 52 or -42.98% compared to the previous year.

Employees
69
Change (1Y)
-52
Growth (1Y)
-42.98%
Revenue / Employee
$515,101
Profits / Employee
-$900,623
Market Cap
740.19M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202569-52-42.98%
Dec 31, 2024121-1-0.82%
Dec 31, 202312243.39%
Dec 31, 2022118-60-33.71%
Dec 31, 20211783221.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company Name Employees
Rigel Pharmaceuticals 174
Allogene Therapeutics 152
Aura Biosciences 113
Inventiva 77
SpyGlass Pharma 68
Oculis Holding AG 60
Candel Therapeutics 55
Climb Bio 29
Employee Rankings

CTMX News

More News